CCEL - CRYO CELL INTERNATIONAL INC

3.58
0.020   0.556%

Share volume: 1,522
Last Updated: 04-22-2026
Healthcare/Services – Health: 0.01%

PREVIOUS CLOSE
CHG
CHG%
$3.56
0.02
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
64%
Profitability 66%
Dept financing 43%
Liquidity 8%
Performance 80%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0.56%
1 Month
14.74%
3 Months
4.99%
6 Months
-19.37%
1 Year
-36.64%
2 Year
-53.63%
Key data
Stock price
$3.58
P/E Ratio 
0.00
DAY RANGE
$3.56 - $3.58
EPS 
$0.17
52 WEEK RANGE
$2.72 - $6.35
52 WEEK CHANGE
-$37.52
MARKET CAP 
27.388 M
YIELD 
19.12%
SHARES OUTSTANDING 
8.055 M
DIVIDEND
$0.25
EX-DIVIDEND DATE
02-14-2025
NEXT EARNINGS DATE
N/A
BETA 
0.42
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$10,113
AVERAGE 30 VOLUME 
$11,671
Company detail
CEO: David I. Portnoy
Region: US
Website: cryo-cell.com
Employees: 90
IPO year: 2007
Issue type: Common Stock
Market: NYSE American
Industry: Healthcare/Services – Health
Sector: Services

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells. The company also manufactures and sells PrepaCyte CB processing system. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide.

Recent news